This day highlights the importance of retinal health and the challenges faced by people living with retinal diseases. It is observed annually on the last Sunday of September to inform people about retinal health and raise awareness of degenerative retinal diseases. This day aims to unite scientists and doctors in the search for a cure for Retinitis Pigmentosa ( RP ) and all diseases that in one way or another cause damage to the retina.

Latest developments in retinitis pigmentosa (RP) research focus on gene therapies, stem cell therapies, and optogenetic therapies, with some treatments showing promise in clinical trials for restoring vision or slowing disease progression. While gene therapy has shown success for specific gene mutations, other new approaches like optogenetics aim to make surviving retinal cells light-sensitive, and stem cell therapies attempt to replace damaged cells. N-acetylcysteine (NAC) is also being studied for its potential to improve vision and light sensitivity, and retinal implants offer a way to restore function for advanced cases
Gene Therapies
- Corrective Gene Therapy:
Involves introducing a healthy copy of a gene to replace a faulty one, with one form already approved for a specific RP variant (RPE65).
- Optogenetic Therapy:
Uses viral vectors to deliver genes that make retinal cells, including those that are not normally light-sensitive, capable of responding to light to restore vision.
Stem Cell Therapy
- Cell Regeneration:
A promising experimental approach involves injecting stem cells to potentially regenerate damaged or dying retinal cells.
- Paracrine Effect:
Some stem cells used in trials have a paracrine effect, releasing growth factors that can help rescue or save malfunctioning cells in the retina.
Retinal Implants and Prosthetics
- “Bionic Eyes”:
Devices like the Argus II can provide some vision for individuals with advanced RP by bypassing damaged photoreceptors and directly stimulating retinal neurons.
- Photoswitch Molecule:
Research is exploring KIO-301, a molecule that can give light sensitivity to retinal ganglion cells, which are often preserved in advanced RP.
Other Promising Research
- N-acetylcysteine (NAC):
An oral supplement being tested in a large clinical trial for its potential to improve visual acuity and light sensitivity.
- Gene-Editing Techniques:
Technologies like CRISPR are being used to correct disease-causing gene mutations.
Important Considerations
- No Universal Cure:
Currently, no single treatment is effective for all forms of RP, and many treatments are still under development or experimental.
- Genetic Counseling:
Recommended for families affected by RP to understand inheritance patterns, risks, and potential genetic testing.
- Supportive Care:
Low vision services, optical aids, and counseling are crucial for managing vision loss and improving quality of life.


